Federal Issues

MassBio is  front and center on Capitol Hill when it comes to advocating for policies that will pave the way for innovation. We fight for the laws and regulations that will speed the development of treatments and cures for Alzheimer's, Diabetes, HIV/AIDs and other ailments. We work for policies that will help bring those drugs to the market and make them available to all.

 

NEW! MassBio polled the candidates for the U.S. Senate seat on issues critical to the biotechnology industry. See their answers to the questions here.

 

To download the 2009 MassBio Federal Policy White Paper, click here.

Stem Cell Research

Strong government support will help foster research on human stem cells, one of the most promising areas of research in the medical field today.
Read more

Patent Reform

It is crucial to strengthen the existing patent system to attract investors who can help the biotechnology industry to grow.
Read more

Biosimilars

As biotechnology drugs hit the market, companies will look to copy them. Appropriate regulations are needed to protect the health and safety of consumers and encourage more development.
Read more

Prescription Drug User Fee Act (PDUFA)

The user fee program adopted by Food and Drug Administration has significantly improved the efficiency of licensing drugs without compromising safety.
Read more

Small Business Innovation Research Program (SBIR)

Access to these grants that provide significant assistance to small companies working on critical research must be expanded to ensure a stronger drug pipeline.
Read more

National Institutes of Health Funding

The funding provided by the National Institutes of Health enables basic research that provides the fundamental building blocks for innovation.
Read more

Drug Price Controls

The biotechnology industry in the United States is strong because the nation has resisted the urge to adopt artificial price controls that have hindered innovation elsewhere.
Read more

Drug Importation

Strong federal policy is necessary to protect the safety of the American public and ensure the strength of the U.S. market.
Read more

About MassBio

MassBio, founded in 1985, is a not-for-profit organization committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.

image of rss iconLatest Updates